COPD Therapeutics Market Analysis

The global COPD therapeutics market is segmented and analyzed for demand and supply by age group into below 5 years, 5-14 years, 15-60 years, and above 60 years. Among these segments, the 15-60 years segment is anticipated to capture the largest market size in the global COPD therapeutics market owing to the growing prevalence of asthma and COPD among this age group. As per the data by the Centers for Disease Control and Prevention, a total of 21,030,479 (8.4%) adults aged over 18 years were diagnosed with asthma in the United States in 2020, which was a significant increase over the previous year. Moreover, almost ~2 million adults aged over 18 years had emphysema in 2018, a common COPD condition in the United States.  Thus, the rising prevalence of COPD conditions among adults is anticipated to drive segment growth during the forecast period.

Our in-depth analysis of the market includes the following segments